Cy R. Wilkins: Treating Chemotherapy-Induced Thrombocytopenia Beyond the Platelet Count
Cy R. Wilkins, Assistant Attending Physician of Hematology Service at Memorial Sloan Kettering Cancer Center, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in American Journal of Hematology, adding:
“Does treating chemotherapy-induced thrombocytopenia actually change outcomes that matter to patients — or just the platelet count?
In our study, recently published in the American Journal of Hematology, we compared 165 romiplostim-treated patients with solid tumors and persistent CIT vs. 165 rigorously matched controls:
Takeaway:
- Dose intensity: Significantly fewer chemotherapy dose modifications with romiplostim (45% vs. 66%, p<0.001)
- Survival: No significant difference in 2-year OS overall (HR 0.80); significant mortality reduction in the metastatic subgroup (HR 0.70, p=0.02)
- Safety: No increased signal for VTE, arterial thrombosis, or major bleeding
Grateful to co-authors Divyash Shah, Jeffrey Zwicker, and Avi Leader.”
Title: Clinically Relevant Outcomes With Romiplostim in Patients With Solid Tumors and Persistent Chemotherapy Induced Thrombocytopenia
Authors: Cy R. Wilkins, Divyash Shah, Andriy Derkach, David Nemirovsky, Laurent Frenzel, Jodi V. Mones, Rekha Parameswaran, Emily Shteynberg, Galia Spectre, Simon Mantha, Jeffrey I. Zwicker, Avi Leader
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery